All News

In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.

It was a busy week for the Contemporary OB/GYN® team.

At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.

Risk assessment, lifestyle counseling, adverse effects, and medication management.

Understanding the technology behind a newer uterus-sparing option for the management of uterine fibroids.

Through its new Visiting Scientist Program and Digital Innovation Fellowship, Maven aims to improve its care model and continue improving prenatal health outcomes.

Protocol 5 - In this protocol, Norton reviews the pathophysiology of fetal aneuploidy and the wide range of tests for it. Included are perspectives on cell-free DNA testing, first-trimester combined screening, nuchal translucency (NT) sonography, and pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG), as well as quad marker screening in the second trimester in appropriate cases, and combined first- and second-trimester screening.

American Heart Month serves as a reminder for health care providers to not only provide the best care possible to their patients but also prioritize their own health.

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.

The campaign emphasizes the importance of annual cancer screenings with the Queen of Hip-Hop Soul

The research team found that levels of depression are at least 3 times higher than before the COVID-19 pandemic.

The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.

A look at what's coming to Contemporary OB/GYN® this week.

The results of a new UCLA-led study show that the pandemic has exacerbated disparities in care, widening inequities.

It's been a busy week for the Contemporary OB/GYN® team. Here's a look at what you missed.

Women with severe menopausal symptoms are likely to experience significantly greater cognitive decline than their counterparts with mild menopausal symptoms, according to a cross-sectional study in the journal Menopause.

Payments are meant to assist providers who have been impacted by the COVID-19 pandemic.

Difficulties accessing virtual care and support remain a barrier to the best care for patients facing complex conditions.

For preeclampsia, multifetal gestation was the most common high-risk factor among pregnant patients who gave birth in the United States in 2019.

Americans want the technology available, but most prefer in-person visits.

These results suggest that maternal diet during pregnancy can significantly affect obesity risk in children.

The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy.

First-time visits up sharply, study finds.

Research in the journal Cell Reports concludes that the discovery of a hormone-sensing pathway in Candida albicans, which enables the fungus to adapt to estrogen, could help explain gender biases linked to fungal infections and might provide an alternative approach to improving women's health.

Women with non-albicans Candida (NAC) vulvovaginal candidiasis (VVC) were nearly twice as likely to have multiple physician visits for recurring infections compared to women who had C. albicans (CA) VVC, according to a retrospective chart review in the Journal of Women’s Health.

An oral probiotic formula for the secondary prevention of vulvovaginal infections in pregnant women neither colonized in the vagina nor reduced the rate of repeated vulvovaginal infection, according to a study in the American Journal of Gynecology & Obstetrics.

A look at what's coming to Contemporary OB/GYN® this week.

Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla) transdermal system.